Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial-Reference-Cited by-同舟云学术

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Published:2019-04 Issue: Volume:206 Page:67-74
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Bolt Luke K.,Amminger G. Paul,Farhall John,McGorry Patrick D.,Nelson Barnaby^ORCID,Markulev Connie,Yuen Hok Pan^ORCID,Schäfer Miriam R.,Mossaheb Nilufar,Schlögelhofer Monika,Smesny Stefan,Hickie Ian B.,Berger Gregor Emanuel,Chen Eric Y.H.,de Haan Lieuwe,Nieman Dorien H.,Nordentoft Merete,Riecher-Rössler Anita^ORCID,Verma Swapna,Thompson Andrew,Yung Alison Ruth^ORCID,Allott Kelly A.^ORCID

Funder

Stanley Medical Research Institute

NHMRC Australia Program

Colonial Foundation

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference64 articles.

1. At clinical high risk for psychosis: outcome for non-converters;Addington;Am. J. Psychiatr.,2011

2. The role of cognition and social functioning as predictors in the transition to psychosis for youth with attenuated psychotic symptoms;Addington;Schizophr. Bull.,2017

3. Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation;Allen;Schizophr. Bull.,2015